Darby Thomas, PhD

Darby has more than 25 years of experience in virology, cell and molecular biology, gene and cell therapy and biotechnology. Her experience includes broad experience in adeno-associated virus (AAV) gene therapy with roles in CMC, discovery, translational development and patient advocacy for several gene therapy companies with an emphasis on rare pediatric diseases and ophthalmology.

Joining Fortrea in 2023, Darby provides scientific consultations, trainings, and support for clinical development programs and operational teams utilizing cell or gene therapy modalities.

Darby is based in the US.